Treatment for comorbid diabetes with chronic kidney disease
US9259479B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2013 |
| Grant date | Feb 16, 2016 |
| Priority date | — |
| Expiry date | May 2, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an improved method for treating diabetes wherein the improvement comprises administering a PEGylated insulin compound to a patient having moderate to severe chronic kidney disease using an effective amount of the compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.